Stefan Galluppi

CIK: 0001722649

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LFMD

LifeMD, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

LFMD
LifeMD, Inc.
Aug 22, 2025
Award(A)
Direct
30K shares-
LFMD
LifeMD, Inc.
Jun 13, 2025
Sale(S)
Direct
85K shares at avg. $12.38$1.1M
LFMD
LifeMD, Inc.
Mar 31, 2025
Award(A)
Direct
30K shares-
LFMD
LifeMD, Inc.
Mar 7, 2025
Award(A)
Direct
30K shares-
LFMD
LifeMD, Inc.
Mar 6, 2025
Award(A)
Direct
60K shares-
LFMD
LifeMD, Inc.
Sep 11, 2024
Purchase(P)
Direct
3K shares at avg. $4.93$15K

		Type	Shares	Price		Ownership
Aug 22, 2025	LFMD LifeMD, Inc.	Award(A)	30,000	-	-	Direct
Jun 13, 2025	LFMD LifeMD, Inc.	Sale(S)	85,000	$12.38	$1,052,657	Direct
Mar 31, 2025	LFMD LifeMD, Inc.	Award(A)	30,000	-	-	Direct
Mar 7, 2025	LFMD LifeMD, Inc.	Award(A)	30,000	-	-	Direct
Mar 6, 2025	LFMD LifeMD, Inc.	Award(A)	60,000	-	-	Direct
Sep 11, 2024	LFMD LifeMD, Inc.	Purchase(P)	3,000	$4.93	$14,790	Direct

1-6 of 6 transactions

About Galluppi Stefan

Galluppi Stefan (SEC CIK 0001722649) files insider reports with the SEC as Chief Innovation Officer of LifeMD, Inc. (LFMD).

Signal8 holds 6 ownership filings by Galluppi Stefan, all Form 4s, filed between Sep 12, 2024 and Aug 26, 2025. Those filings report 6 transactions, from Sep 11, 2024 to Aug 22, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Galluppi Stefan's filings is in NEW YORK, NY.

Recent filings by Galluppi Stefan

Aug 22, 2025: Grant or award of LFMD shares (Form 4, code A).
Jun 13, 2025: Open-market sale of LFMD shares (Form 4, code S).
Mar 31, 2025: Grant or award of LFMD shares (Form 4, code A).
Mar 7, 2025: Grant or award of LFMD shares (Form 4, code A).
Mar 6, 2025: Grant or award of LFMD shares (Form 4, code A).

Other insiders filing for LifeMD, Inc. (LFMD)

LAROVERE JOAN, Director
Strawn John R Jr, Director
DiTrolio Joseph, Director
Simon Roberto, Director
MACRAE CALUM ARCHIBALD, Director
Sripad Umesh, Chief Technology Officer

How to read Form 4 transaction codes